Regeneron Pharmaceuticals, Inc. - Strategy and SWOT Report
Regeneron Pharmaceuticals, Inc. - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Detailed information on Regeneron Pharmaceuticals, Inc. required for business and competitor intelligence needs
A study of the major internal and external factors affecting Regeneron Pharmaceuticals, Inc. in the form of a SWOT analysis
An in-depth view of the business model of Regeneron Pharmaceuticals, Inc. including a breakdown and examination of key business segments
Intelligence on Regeneron Pharmaceuticals, Inc.’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
News about Regeneron Pharmaceuticals, Inc., such as business expansion, restructuring, and contract wins
Large number of easy-to-grasp charts and graphs that present important data and key trends
Regeneron Pharmaceuticals (Regeneron or ‘the company’) is a science-based biopharmaceutical company that discovers, invents, develops, manufactures and commercializes medicines. The company primarily operates in the US, where it is headquartered in New York, and employed 2,925 people as on December 31, 2014. The company recorded revenues of $2,819.6 million during the financial year ended December 2014 (FY2014), an increase of 34% over FY2013. The operating profit of the company was $838.4 million in FY2014, an increase of 10.3% over FY2013. The net profit of the company was $348.1 million in FY2014, a decrease of 18% compared with FY2013.
Reasons to Purchase:
Gain understanding of Regeneron Pharmaceuticals, Inc. and the factors that influence its strategies
Track strategic initiatives of the company and latest corporate news and actions
Assess Regeneron Pharmaceuticals, Inc. as a prospective partner, vendor or supplier
Support sales activities by understanding your customers' businesses better
Stay up to date on Regeneron Pharmaceuticals, Inc.’s business structure, strategy and prospects